Accéder au contenu
Merck

Vasorelaxant activities of Danhong injection and their differential effects on the rat abdominal aorta and mesenteric artery.

Journal of cardiovascular pharmacology (2014-09-30)
Xianming Su, Xiaowen Zhi, Ting Cui, Qiaowei Zheng, Shixiang Wang, Yongxiao Cao, Changcong Cui, Weiyi Feng
RÉSUMÉ

Previous studies have found that Danhong injection (DHI), an extensively used herbal extract preparation in China, might be a powerful vasodilator. The aims of this study were to determine the vascular activity of DHI and its effects on arteries of different sizes. The results showed that DHI significantly inhibited rat-hindquarters and rabbit-ear vasoconstriction elicited by norepinephrine (NE) perfusion and markedly relaxed KCl-contracted and NE-contracted rat abdominal aortic and mesenteric artery rings. The endothelium made only a minor contribution to the vasorelaxant effect of DHI on artery segments. The vasorelaxant effect of DHI varied with the artery size, with larger arteries exhibiting a more sensitive and potent vasodilator response. DHI relaxed NE-induced vasoconstriction probably through inhibition of the intracellular Ca2+ release through the inositol triphosphate receptor system in the abdominal aorta and mesenteric artery, along with blockage of extracellular Ca2+ influx through the receptor-linked Ca2+ channels in the mesenteric artery. In addition, DHI completely relaxed KCl-induced contraction in both of the arteries, suggesting that inhibition of Ca2+ influx through voltage-gated Ca2+ channels is involved in the vasorelaxant effect of DHI. This elucidation of the vascular effects of DHI and the underlying mechanisms could lead to improved clinical applications.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Triéthylamine, ≥99.5%
Sigma-Aldrich
Triéthylamine, BioUltra, ≥99.5% (GC)
Supelco
Caféine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Triéthylamine, ≥99%
Sigma-Aldrich
Caféine, powder, ReagentPlus®
Sigma-Aldrich
Caféine, anhydrous, 99%, FCC, FG
Sigma-Aldrich
4-Aminopyridine, 98%
Sigma-Aldrich
4-Aminopyridine, ≥99%
USP
Caféine, United States Pharmacopeia (USP) Reference Standard
USP
Caféine, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Triéthylamine, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
Atropine sulfate salt monohydrate, ≥97% (TLC), crystalline
Supelco
Caféine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Triéthylamine, ≥99.5%
Supelco
Caféine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Triéthylamine, for protein sequence analysis, ampule, ≥99.5% (GC)
Sigma-Aldrich
Triéthylamine, for amino acid analysis, ≥99.5% (GC)
USP
Atropine sulfate, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Caféine, Sigma Reference Standard, vial of 250 mg
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
Supelco
Atropine Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Caféine, anhydrous, tested according to Ph. Eur.
Supelco
Caféine, traceable to primary standards (LGC)
Sigma-Aldrich
Acetylcholine bromide, ≥99%
Supelco
Triéthylamine, analytical standard
Sigma-Aldrich
Caféine, meets USP testing specifications, anhydrous
Sigma-Aldrich
Caféine, BioXtra
Sigma-Aldrich
Phentolamine methanesulfonate salt, ≥98% (TLC), powder
Caféine, European Pharmacopoeia (EP) Reference Standard
Caféine, European Pharmacopoeia (EP) Reference Standard